InspireMD (NSPR) Depreciation & Amortization (CF) (2016 - 2025)
InspireMD filings provide 16 years of Depreciation & Amortization (CF) readings, the most recent being $143000.0 for Q4 2025.
- On a quarterly basis, Depreciation & Amortization (CF) rose 90.67% to $143000.0 in Q4 2025 year-over-year; TTM through Dec 2025 was $476000.0, a 70.0% increase, with the full-year FY2025 number at $476.0 million, up 70.0% from a year prior.
- Depreciation & Amortization (CF) hit $143000.0 in Q4 2025 for InspireMD, up from $128000.0 in the prior quarter.
- In the past five years, Depreciation & Amortization (CF) ranged from a high of $143000.0 in Q4 2025 to a low of $33000.0 in Q2 2021.
- Median Depreciation & Amortization (CF) over the past 5 years was $58000.0 (2023), compared with a mean of $68263.2.
- Biggest five-year swings in Depreciation & Amortization (CF): fell 19.61% in 2022 and later skyrocketed 90.67% in 2025.
- InspireMD's Depreciation & Amortization (CF) stood at $37000.0 in 2021, then surged by 45.95% to $54000.0 in 2022, then rose by 12.96% to $61000.0 in 2023, then rose by 22.95% to $75000.0 in 2024, then soared by 90.67% to $143000.0 in 2025.
- The last three reported values for Depreciation & Amortization (CF) were $143000.0 (Q4 2025), $128000.0 (Q3 2025), and $107000.0 (Q2 2025) per Business Quant data.